Danish businesses are among the world's leading biotech companies, and Danish biotech research is internationally recognised. With growing competition from other countries, the new research centre in Kalundborg will help Denmark maintain and expand this position.
BIOPRO is a collaborative project between leading biotech businesses and universities for the development of solutions to some of the challenges facing biotech manufacturing. It is the ambition to reduce the consumption of raw materials and energy sharply while at the same time markedly increasing the yield. Initially, BIOPRO will be located at Novo Nordisk's and Novozymes' production plants in Kalundborg and employ around 20 people, mainly researchers.
Internationally Ground-Breaking Biotech Project
Managing Director of BIOPRO, Jesper Bryde-Jacobsen, describes the project as ground-breaking on an international level, he says:
- "Firstly, the Partners behind the collaboration are heavyweights in their respective industries and, secondly, by locating the project in Region Zealand, Denmark, we get access to the plants of CP Kelco, DONG Energy, Novo Nordisk and Novozymes where we can conduct full-scale tests. Such a tight coupling between research and manufacture is unique."
- "Therefore, we expect to be able to attract international businesses and researchers who can contribute to the further development of the technology. It is the ambition to create an international cluster as it is known from the IT industry,"
Regional Project Manager at Invest in Denmark, Kristina Sisseck is impressed by the line-up of partners behind the initiative and sees great potential:
- ”If companies can reduce their consumption of raw materials and energy, they will be one step ahead in the international competition. BIOPRO is clearly an interesting platform to advance technologies with this objective, and it is my hope that also foreign companies will become part of, contribute to and not least benefit from this unique project.”
The Partners behind BIOPRO are CP Kelco, DONG Energy, Novo Nordisk and Novozymes as well as the Technical University of Denmark and the University of Copenhagen.
BIOPRO is managed by the innovation and development company CAT, and the project is financed by Region Zealand, the EU and the Partners. The starting budget for the project is around DKK 40 million.